These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2433428)

  • 1. A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions.
    Tedford CE; Schott MJ; Flynn JR; Cannon JG; Long JP
    J Pharmacol Exp Ther; 1987 Feb; 240(2):476-85. PubMed ID: 2433428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in acetylcholine metabolism in rat striatal slices by a 4-methyl piperidine analog of hemicholinium-3.
    Tedford CE; Flynn JR; Bhatnagar RK; Cannon JG; Long JP
    J Pharmacol Exp Ther; 1988 Nov; 247(2):460-5. PubMed ID: 3183948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hemicholinium on behavior and on brain acetylcholine and choline in the rat.
    Freeman JJ; Choi RL; Jenden DJ
    Psychopharmacol Commun; 1975; 1(1):15-27. PubMed ID: 1241449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
    Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M
    Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the behavioral and biochemical effects of hemicholinium in vivo.
    Freeman JJ; Macri JR; Choi RL; Jenden DJ
    J Pharmacol Exp Ther; 1979 Jul; 210(1):91-7. PubMed ID: 448651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term monoamine changes in the striatum and nucleus accumbens after acute chlorpyrifos exposure.
    Moreno M; Cañadas F; Cardona D; Suñol C; Campa L; Sánchez-Amate MC; Flores P; Sanchez-Santed F
    Toxicol Lett; 2008 Jan; 176(2):162-7. PubMed ID: 18164878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanisms of sustained tremor induction by nicotine in pilocarpine treated animals.
    Dohi T; Tsujimoto A
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):62-72. PubMed ID: 153736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various dose-dependent influences of apomorphine on the acetylcholine turnover in striatum and mesolimbic areas of rat brain.
    Langnickel R; Bluth R; Oelssner W
    Biomed Biochim Acta; 1983; 42(7-8):937-46. PubMed ID: 6651810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hemicholinium-3 and physostigmine on choline in rat brain.
    Slone HT; Kosh JW; Freeman JJ
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):133-6. PubMed ID: 3715194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-4, a tertiary amine analog of HC-3, lowers arterial pressure in spontaneously hypertensive rats.
    Ozkutlu U; Shaffer RA; Lewis SJ; Long JP
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1352-8. PubMed ID: 8667197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oxiracetam and piracetam on central cholinergic mechanisms and active-avoidance acquisition.
    Spignoli G; Pedata F; Giovannelli L; Banfi S; Moroni F; Pepeu G
    Clin Neuropharmacol; 1986; 9 Suppl 3():S39-47. PubMed ID: 3594455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain.
    Ardis TC; Cahir M; Elliott JJ; Bell R; Reynolds GP; Cooper SJ
    J Psychopharmacol; 2009 Jan; 23(1):51-5. PubMed ID: 18562433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and behavioral studies on the mode of action of oxypertine.
    Moroji T; Okuyama T; Hagino Y; Sekiguchi R
    Arzneimittelforschung; 1986 May; 36(5):804-8. PubMed ID: 2873819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
    Wong DT; Threlkeld PG; Bymaster FP
    Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF; Segovia G; Mora F
    Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission.
    Amenta F; Tayebati SK; Vitali D; Di Tullio MA
    Mech Ageing Dev; 2006 Feb; 127(2):173-9. PubMed ID: 16297435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylpiperidine analog of hemicholinium-3: a selective, high affinity non-competitive inhibitor of sodium dependent choline uptake system.
    Chatterjee TK; Long JP; Cannon JG; Bhatnagar RK
    Eur J Pharmacol; 1988 May; 149(3):241-8. PubMed ID: 3409952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.
    Hellweg R; Zueger M; Fink K; Hörtnagl H; Gass P
    Neurobiol Dis; 2007 Jan; 25(1):1-7. PubMed ID: 16990008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.